Contemporary drug synthesis

Jie Jack Li ... [et al.]

An integrated and insightful look at successful drug synthesis in today's drug discovery market The pharmaceutical industry is unquestionably vibrant today, with drug synthesis making a vital contribution. Whether in the early developmental stages of identifying and optimizing a lead, or the latter stages of process development and cost-effective scale-up, the ability to design elegant and economical synthetic routes is often a major factor in the eventual viability and commercial success of a drug. Contemporary Drug Synthesis examines how leading researchers and manufacturers have integrated chemistry, biology, pharmacokinetics, and a host of other disciplines in the creation and development of leading drugs. Authored by four of the pharmaceutical industry's most respected scientists, this timely volume: * Focuses on the processes that resulted in high-profile drugs including Lipitor, Celebrex, Viagra, Gleevec, Nexium, Claritin, and over a dozen others * Provides an in-depth introduction to each drug, followed by a detailed account of its synthesis * Organizes the drugs into fourteen therapeutic areas for clarity and ease of useProcess chemists provide an essential bridge between chemistry and the marketplace, creating scientifically practical drug processes while never losing sight of the commercial viability of those processes. Contemporary Drug Synthesis meets the needs of a growing community of researchers in pharmaceutical research and development, and is both a useful guide for practicing pharmaceutical scientists and an excellent text for medicinal and organic chemistry students.

「Nielsen BookData」より

[目次]

  • Preface. Trade Names and Their Corresponding USANs. Acronyms and Abbreviations. Chapter 1. Antithrombotics: Ticlopidine (Ticlid(r)) and Clopidogrel (Plavix(r)). Chapter 2. Anti-inflammatory Cyclooxygenase-2 Selective Inhibitors: Celecoxib (Celebrex(r)) and Rofecoxib (Vioxx(r)). Chapter 3. H+/K+ -ATPase Inhibitors: Esomeprazole (Nexium(r)). Chapter 4. Protein-tyrosine Kinase Inhibitors: Imatnib (Gleevec(r)) and Gefitinib (Iressa(r)). Chapter 5. Non-sedating Antihistamines. Chapter 6. Cosmeceuticals: Istretinoin (Accutane(r)), Tazarotene (Tazorac(r)), Minoxidil (Rogaine(r)), and Finasteride (Propecia(r)). Chapter 7. Antibacterials: Ciprofloxacin (Cipro(r)) and Linezolid (Zyvox(r)). Chapter 8. Atypical Antupsychotics. Chapter 9. Atovastatin Calcium (Lipitor(r)). Chapter 10. Antidepressants. Chapter 11. Anti-obesity: Orlistat (Xenical(r)). Chapter 12. Triptans for Migrane. Chapter 13. PDE 5 Inhibitors for Erectile Dysfunction: Sildenafil (Viagra(r)), Vardenafil (Levitra(r)), and Tadalafil (Cialis(r)). Chapter 14. Antiasthmatics. Index.

「Nielsen BookData」より

この本の情報

書名 Contemporary drug synthesis
著作者等 Li, Jie Jack
Roth, Bruce D.
Sliskovic, Drago R.
Johnson Douglas S.
出版元 Wiley-Interscience
刊行年月 c2004
ページ数 xv, 221 p.
大きさ 25 cm
ISBN 0471214809
NCID BA74678901
※クリックでCiNii Booksを表示
言語 英語
出版国 アメリカ合衆国
この本を: 
このエントリーをはてなブックマークに追加

このページを印刷

外部サイトで検索

この本と繋がる本を検索

ウィキペディアから連想